CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Hemagen Diagnostics, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Hemagen Diagnostics, Inc.
9033 Red Branch Rd
Phone: (443) 367-5500p:443 367-5500 COLUMBIA, MD  21045-2396  United States Ticker: HMGNHMGN
This company ceased filing statements with the SEC on 1/30/2013.
Business Summary
Hemagen Diagnostics, Inc. is engaged in providing clinical diagnostic solutions. The Company is primarily focused on Veterinary Clinical Diagnostics. It is also focused on VIRGO, its Human Clinical Diagnostic line of autoimmune and infectious disease products. The Company develops, manufactures and markets a range of test kits used to aid in the diagnosis of certain autoimmune and infectious diseases. The Company’s autoimmune product portfolio includes Hemagen DNA Kit, Hemagen Rheumatoid Factor Kit, VIRGO AMA IgG, VIRGO ANA/Hep-2 IgG, VIRGO Anti-nDNA IgG, VIRGO cANCA (PR-3) Kit, VIRGO dsDNA Kit, VIRGO ENA Screen 6 Kit, VIRGO ENA Screening, VIRGO ENA Series, VIRGO pANCA myeloperoxidase (MPO) Kit and VIRGO Rheumatoid Factor Kit. It offers various products for infectious disease, which includes VIRGO C. trach IgG, VIRGO CMV IgG and VIRGO epstein-barr virus (EBV)- viral capsid antigen (VCA) IgG. Its products are used in laboratories, hospitals and blood banks around the world.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20129/30/2012YesYes--Yes

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer William P.Hales 50 2/1/2004 10/1/1999
Chief Financial Officer M. RobertCampbell 43 1/9/2013 1/9/2013
Principal Accounting Officer, Controller Catherine M.Davidson 47 1/9/2013 4/1/2007
Independent Director Alan S.Cohen 86 1/1/1993 1/1/1993
Independent Director Edward T.Lutz 66 2/25/2004 2/25/2004

Business Names
Business Name
Hemagen Diagnostics, Inc.
HMGN
Reagents Applications, Inc.

General Information
Number of Employees: 15 (As of 9/30/2012)
Outstanding Shares: 15,500,281 (As of 12/13/2012)
Shareholders: 1,233
Stock Exchange: OTC
Federal Tax Id: 042869857
Fax Number: (443) 367-5527
Email Address: info@hemagen.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023